ALLM-Ab: Active Learning-Driven Antibody Optimization Using Fine-Tuned Protein Language Models

Antibody engineering requires a delicate balance between enhancing binding affinity and maintaining developability properties. In this study, we present ALLM-Ab (Active Learning with Language Models for Antibodies), a novel active learning framework that leverages fine-tuned protein language models to accelerate antibody sequence optimization. By employing parameter-efficient fine-tuning via low-rank adaptation, coupled with a learning-to-rank strategy, ALLM-Ab accurately assesses mutant fitness while efficiently generating candidate sequences through direct sampling from the model's probability distribution. Furthermore, by integrating a multiobjective optimization scheme incorporating antibody developability metrics, the framework ensures that optimized sequences retain therapeutic antibody-like properties alongside improved binding affinity. We validate ALLM-Ab in both offline experiments using deep mutational scanning (DMS) data from the BindingGYM data set and online active learning trials targeting Flex ddG energy minimization across 15 antigens. Results demonstrate that ALLM-Ab not only expedites the discovery of high-affinity variants compared to baseline Gaussian process regression and genetic algorithm-based approaches, but also preserves critical antibody developability metrics. This work lays the foundation for more efficient and reliable antibody design strategies, with the potential to significantly reduce therapeutic development costs.